Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason L. Groves currently holds 21,338 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason L. Groves has been a net seller of NRBO stock. They have purchased $0 and sold $103.2K worth of shares.
Jason L. Groves's most recent insider trade was on Jun 8, 2026, when they sold 17,186 shares at $0.00 per share.
Jason L. Groves serves as Executive at NeuroBo Pharmaceuticals, Inc. (NRBO). They have executed 14 insider transactions totaling $103.2K over their tenure at the company.
Jason L. Groves holds the position of Executive at NeuroBo Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Jason L. Groves has shown a selling trading pattern, with $0 in total purchases and $103.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason L. Groves was on Jun 10, 2014, when they sold $103.2K worth of MED shares. This transaction involved 3,250 shares at $31.75 per share.
Jason L. Groves currently owns 21,338 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason L. Groves's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason L. Groves has 14 Form 4 filings on record as an insider at NeuroBo Pharmaceuticals, Inc..
Set alerts for Jason L. Groves and 40,000+ other insiders.